Your browser doesn't support javascript.
loading
Software-designed miniproteins could create new class of drugs.
Service, Robert F.
Science ; 376(6588): 17, 2022 04.
Article in En | MEDLINE | ID: mdl-35357932
ABSTRACT
Small versions of antibodies bind to virtually any target protein.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Software / Drug Design / Antibodies Language: En Journal: Science Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Software / Drug Design / Antibodies Language: En Journal: Science Year: 2022 Document type: Article